Bayer Aktiengesellschaft (ETR:BAYN) Trading Up 1.8% – Still a Buy?

Bayer Aktiengesellschaft (ETR:BAYN) shot up 1.8% during trading on Thursday . The company traded as high as €34.77 and last traded at €34.70. 3,013,207 shares traded hands during trading, The stock had previously closed at €34.10.

Bayer Aktiengesellschaft Stock Performance

The firm has a 50 day moving average of €38.57 and a two-hundred day moving average of €38.71. The stock has a market cap of $35.03 billion, a P/E ratio of -39.81, a P/E/G ratio of 36.39 and a beta of 0.84. The company has a debt-to-equity ratio of 134.81, a quick ratio of 0.72 and a current ratio of 1.06.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.